Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Sridhar Rao MD, PhD
Associate Professor
Department of Pediatrics
Division of Hematology and Oncology - Pediatrics

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226
Phone: 414-937-3841
Fax: 414-937-6284
Email: srrao@mcw.edu

EDUCATION:
09/1990 - 06/1994 BChE - Chemical Engineering, University of Minnesota, MN
07/1994 - 06/2001 MD, University of Chicago, Chicago, IL
07/1996 - 06/1999 PhD - Pathology, University of Chicago, Chicago, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/01/2001 - 06/30/2004 Resident, Pediatrics, Children's Hospital, Boston, Boston, MA
07/01/2004 - 06/30/2007 Clinical Fellow, Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA
07/01/2005 - 11/30/2010 Research Fellow, Pediatric Oncology, Laboratory of Dr. Stuart H. Orkin, Dana Farber Cancer Institute, Boston, MA

FACULTY APPOINTMENTS:
07/2007 - 11/2010 Instructor, Department of Pediatrics, Harvard Medical School, Cambridge, MA
12/2010 - Present Associate Investigator, Blood Research Institute, Stem Cell Biology Program, BloodCenter of Wisconsin, Milwaukee, WI
07/01/2011 - 06/30/2018 Assistant Professor, Cell Biology, Neurobiology, and Anatomy, MCW, Milwaukee, WI
08/01/2011 - 06/30/2018 Assistant Professor, Pediatrics, Hematology/Oncology/Transplantation, MCW, Milwaukee, WI
07/01/2018 - Present Associate Professor, Pediatrics, Hematology, Oncology, Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI
07/01/2018 - Present Associate Professor, Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
07/2007 - 11/2010 Attending, Pediatric Oncology, Division of Hematopoietic Stem Cell Transplantation, Dana Farber Cancer Institute, Boston, MA
07/2007 - 11/2010 Attending, Medicine, Division of Hematology/Oncology, Children’s Hospital, Boston, MA
07/01/2010 - Present Staff Physician, Pediatrics, Bone Marrow Transplantation, Children's Hospital of Wisconsin, Milwaukee, WI
03/01/2020 - Present Medical Director-Radiation Injury Treatment Network, Children's Hospital of Wisconsin, Milwaukee, WI

RESEARCH ADMINISTRATIVE APPOINTMENTS:
2016 - Present Biology Chair-T2016-003, Therapeutic Advances in Childhood Leukemia (TACL) consortium, Los Angeles, CA
2018 - Present Associate Program Director-MSTP Program, Medical College of Wisconsin

HOSPITAL STAFF PRIVILEGES:
07/2007 - 11/2010 Inpatient Attending, Hematopoietic Stem Cell Transplantation, Children's Hospital, Boston, MA
07/2007 - 11/2010 Outpatient Attending, Hematopoietic Stem Cell Transplantation, Dana Farber Cancer Institute, Boston, MA
12/2010 - Present Inpatient Attending, Hematopoietic Stem Cell Transplantation, Children's Hospital of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Certificates
Issued By Issue DateExpiration
General Pediatrics
American Board of Pediatrics
2004
2011
Pediatric Hematology/Oncology
American Board of Pediatrics
2009
2021
 

Licensure
Number Issue DateExpiration
Massachusetts Full Medical License
2005
None
Wisconsin Full Medical License
55842-20
06/01/2011
10/31/2021
 

AWARDS AND HONORS:
05/2001 AOA Membership, University of Chicago Pritzker School of Medicine
06/2001 Graduation with Honors, University of Chicago Pritzker School of Medicine
09/2011 Dr Richard Aster Award, Blood Research Institute, Milwaukee, WI
2017 - 2018 Outstanding Graduate School Educator, MCW

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2007 - Present American Society of Hematology (Member)
2007 - 2019 American Society of Blood and Marrow Transplantation (Member)
2010 - 2019 International Society of Stem Cell Research (Member)
2019 - Present American Association for Cancer Research (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
01/01/2020 - 12/31/2022 Blood

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
07/01/2020 - 06/30/2024 Permanent Member, Dev2 Study Section, NIH CSR

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Epigenetic Reprogramming in Relapse AML
Source:
Bear Necessities Pediatric Cancer Foundation
Role:
co-Investigator
PI:
M. Burke
Dates:
07/01/2016 - 06/30/2017
Direct Funds:
$20,000 (Currently in a no-cost extension)
 
Title:
GATA4 in Development of a Normal Squamocolumnar Junction and Barrett’s Esophagus
Source:
NIH/NIDDK
Role:
co-Investigator
PI:
M. Battle
Dates:
07/01/2017 - 06/30/2019
Direct Funds:
$5,513
 
Title:
Cohesin Mutations in AML
Source:
NIH/NCI
Role:
PI
PI:
Rao
Dates:
08/22/2017 - 06/30/2022
Direct Funds:
$250,000
 
Prior
Peer Review
Title:
NICHD Child Health Research Scholar
Source:
Career Development Award, NIH/NICHD 5K12HD052896
Role:
Research Scholar
Dates:
07/2007 - 06/2008
 
Title:
Identification of Master Regulators for Early Lineage Commitment
Source:
Seed Grant, Harvard Stem Cell Institute
Role:
Co-Investigator
Dates:
07/2007 - 06/2009
Direct Funds:
$45,000 (The major goals of this project are to identify master regulators of early lineage commitment to the mesoderm and cardiac lineage using a genetic screen)
 
Title:
Exploring the Transcriptional Network Regulating ES cell Pluripotency
Source:
Career Development Award, NIH/NHLBI 5K08HL87951
Role:
Principal Investigator
PI:
Self
Dates:
07/2007 - 06/2012
Direct Funds:
$125,000 (The major goal of this project is to understand the transcriptional mechanisms used by mESC to maintain a pluripotent state utilizing multiple genome-wide techniques.)
 
Title:
Identifying shared transcriptional programs between leukemic and embryonic stem cells
Source:
MCW Cancer Center Pilot Grant
Role:
Principal Investigator
Dates:
07/2012 - 06/2013
Direct Funds:
$30,000 (The major goal of this project is to identify shared transcriptional programs between different types of normal and abnormal stem cells)
 
Title:
Leukemia Stem Cells in ALL
Source:
MACC Fund Novel Initiative Award
Role:
Principal Investigator
Dates:
09/2012 - 09/2013
Direct Funds:
$35,000 (The major goal of this project was to assess the role of Sall4 in development of ALL stem cells)
 
Title:
Leukemia: molecular and cellular mechanisms of pathogenesis and immunotherapy
Source:
Large Center Grant Pilot Funding for Cancer Research
Role:
Project Leader
Dates:
01/2013 - 12/2013
Direct Funds:
$31,000 (The major goal of this project is to assess the role of secondary mutations in the cohesion complex on AML pathogenesis)
 
Title:
Molecular Basis of Human Hepatic Progenitor Cell Formation
Source:
NIH/NIDDK
Role:
CO-Investigator
Dates:
07/2014 - 07/2016
Direct Funds:
$10,000 (Our contribution is solely computational biology support, specifically the analysis and integration of ChIP-seq and transcriptome datasets. )
 
Title:
The Role of Cohesin Proteins in Acute Myelogenous Leukemia
Source:
Hyundai Hope on Wheels
Role:
Principal Investigator
Dates:
01/2015 - 01/2017
Direct Funds:
$125,000
 
Title:
Role of Enhancer-Transcribed RNAs and Tet Proteins in Stem Cells
Source:
American Society of Hematology
Role:
Principal Investigator
Dates:
03/2015 - 03/2016
Direct Funds:
$150,000
 
Non-Peer Review
Title:
Role of Cohesin Mutations in Leukemia
Source:
Heartland Blood Center
Role:
co-PI
PI:
Rao and Crispino
Dates:
10/01/2015 - 09/30/2017
Direct Funds:
$100,000
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
The role of Sall4 isoforms in mESC pluripotency, Oral Presentation, Department of Pediatric Oncology, DFCI retreat, 2009
Identification of Master Regulators for Early Lineage Commitment, Oral Presentation, Harvard Stem Cell Institute retreat, 2009
 
Regional
Cohesin Mutations in AML, University of Milwaukee, Dept of Biology, Invited Seminar, Milwaukee, Wisconsin, 2019
 
National
S Rao, Cohesin Mutations in AML, Invited Departmental Seminar, IUPUI-South Bend/Notre Dame, 2016
Cohesin Mutations in AML, University of Michigan, Dept of Pathology Invited Seminar, Ann Arbor, Michigan, 2017
S Rao, Cohesin Mutations in AML, Invited Departmental Seminar, Northwestern University, Dept. of Cell Biology, 2017
Cohesin Mutations in AML, Well's Center (IUPUI) Invited Seminar, Indianapolis, Indiana, 2018
Cohesin Mutations in AML, University of Pennsylvania, Hematopoiesis Research Affinity Group, Invited Lecture, Philadelphia, Pennsylvania, 2019
3D chromatin structure in development and leukemia, University of Wisconsin, Department of Cell Biology, Invited Seminar, Madison, Wisconsin, 2020
 
International
The role of Sall4 in Embryonic Stem Cell Pluripotency (Oral presentation of Abstract), ASBMT/CIMBTR tandem meetings, Orlando, FL, 2010
Genetic Interaction between Cohesin and Driver Mutations in AML Genetic Interaction between Cohesin and Driver Mutations in AML Genetic Interaction between Cohesin and Driver Mutations in AML Genetic interactions between cohesin and driver mutations in AML, American Society of Hematology, Myeloid Workshop, Orlando, Florida, 2019
 

COMMITTEE SERVICE:
Medical College of Wisconsin
2011 - 2018 Member, Medical Scientist Training Program Admissions Committee, MCW
09/01/2015 - 06/01/2017 Member, CBNA Search Committee
2016 - 2017 Member, Section Chief Search, Hematology, Oncology, and Transplantations, Pediatrics
02/01/2020 - Present Co-Chair, MCW Research Culture Workgroup, Dean's Office, MCW
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
2017 Tumor Immunology for M2
 
Graduate Student Education
2014 - Present Advanced Stem Cell Biology
2015 - 2020 Molecular Techniques, Introduction to RNA-seq
2017 - Present Advanced Cell Biology
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Jeremy Allred, Medical College of Wisconsin, 2010 - 2012 Primary Research Mentor
Jennifer Miksanek, Medical College of Wisconsin, 2012 - 2016 Primary Research Mentor
Emily Philips, Medical College of Wisconsin, 2015 - 2019 Primary Research Mentor
Lauren Engel, Medical College of Wisconsin, 2016 - 2019 Primary Research Mentor
John Brennan, Medical College of Wisconsin, 2017 - 2021 Primary Research Mentor
 
Graduate Students
PhD Committees
Cayla Lillge, Medical College of Wisconsin, 2012 - 2017 GATA4 Regulates Regionalization Along the Small Intestine Epithelium.
Jamie Karcher, Medical College of Wisconsin, 2012 - 2014 High Salt Diet Suppresses the Angiogenic Competency of Bone Marrow Mononuclear Cells in the Rat.
Amanda Urick, Medical College of Wisconsin, 2013 - 2017 BMP Signaling and its Downstream Effector SMAD1 are Necessary for Hepatic Progenitor Cell Formation in hiPSCs
Dan Schill, Medical College of Wisconsin, 2014 - 2018 FoxO1 and FoxA1/2 interdependent and cooperative binding at insulin sensitive genes
Michael Flinn, Medical College of Wisconsin, 2014 - 2018 The Hippo pathway's role in zebrafish cardiac development and regeneration
Matt Waas, Medical College of Wisconsin, 2014 - 2019 Development, Validation, and Application of Strategies for Immunophenotyping Human Pluripotent Stem Cell-Derived Cardiomyocytes
David Schauder, Medical College of Wisconsin, 2014 - Present CD8 T cell differentiation during acute and chronic infections
Kathleen Dixon, Medical College of Wisconsin, 2015 - 2019 The Role of MyD88 in NK cell Maturation and Function
Emily Gronseth, Medical College of Wisconsin, 2015 - Present
Joshua Nord, Medical College of Wisconsin, 2015 - 2019 A Role for Fox01 in Early Development
Cheng-Yin Yuan, Medical College of Wisconsin, 2015 - Present
Timothy Stodola, Medical College of Wisconsin, 2016 - 2018 Structure and Function of the Genome within as SS-13BN Congenic Region
Kathryn Hendee, Medical College of Wisconsin, 2016 - 2019 Axenfeld-Rieger Syndrome:Insights from the Zebrafish Model
Tiffany Claeys, Medical College of Wisconsin, 2017 - Present
Theresa Bluemn, Medical College of Wisconsin, 2017 - Present
Melissa Anfinson, Medical College of Wisconsin, 2018 - Present
Nathan Eaton, Medical College of Wisconsin, 2018 - Present
Benjamin O'Brien Hokanson, Medical College of Wisconsin, 2018 - Present
Luke Christiansen, Medical College of Wisconsin, 2018 - Present
Paystar Topchyan, Medical College of Wisconsin, 2019 - Present
Yao Chen, Medical College of Wisconsin, 2019 - Present
Kyle Stoltz, Medical College of Wisconsin, 2020 - Present
Ao Mei, Medical College of Wisconsin, 2020 - Present
Elaheh Hashemi, Medical College of Wisconsin, 2020 - Present
Lishu He, Medical College of Wisconsin, 2020 - Present
PhD Students Advised
Steven Blinka, Medical College of Wisconsin, 2013 - 2017 Transcribed cis-Regulatory Elements Differentially Regulate Neighboring Genes at the Nanog Locus
Michael Reimer, Medical College of Wisconsin, 2013 - 2019 Differential Roles of TET Proteins in mESC Pluripotency
Puja Agarwal, Medical College of Wisconsin, 2017 - Present
Katelyn Heimbruch, Medical College of Wisconsin, 2017 - Present
 
Clinical/Research Fellows
Samuel Milanovich, Medical College of Wisconsin, 2011 - 2014 Primary Research Mentor
Jonathan Roberts, MD, MCW, 2012 - 2014 Scholarship Committee
Lauren Pommert, Medical College of Wisconsin, 2017 - 2019 Primary Research Mentor
Tyce Kearl, Medical College of Wisconsin, 2018 - 2020 Scholarship Oversight Committee
Michael Halyko, Medical College of Wisconsin, 2019 - 2021 Scholarship Oversight Committee
Amanda Schusterman, Medical College of Wisconsin, 2019 - Present Scholarship Oversight Committee
Matthew Kudek, Medical College of Wisconsin, 2019 - 2021 Scholarship Oversight Committee
 
Faculty
Karen Sue Carlson, Medical College of Wisconsin, 2018 - Present Mentorship Committee Member
Lauren Pommert, Medical College of Wisconsin, 2020 - Present Primary Research Mentor
 
Pharmacy Students
Noe Somo, Medical College of Wisconsin, 2020 - Present Primary Research Mentor
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Clinical/Research Fellows
Joseph Fisher, Blood Research Institute, 2015 - 2017 Primary
 

AD HOC REVIEWER:
06/2012 Dev2 Study Section (NIH)
02/2013 Dev2 Study Section (NIH)
11/2013 Dev2 Study Section (NIH)
11/2013 SEP-PAR13-095(NIH)
02/2014 SEP-PAR13-095(NIH)
02/2015 SEP-PAR13-095(NIH)
2016 Leukemia Research Foundation
2016 NYSTEM reviewer
2017 Dev2 Study Section

THESIS:
The Role of PU.1 and Spi-B in B-lymphocyte Function


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Sielaff, T., Hu, M., Rao, S., Groehler, K., Olson, D., Mann, H., Remmel, R., Shatford, R., Amiot, B., Bloomer, J., Hu, W., and Cerra, F. (1995). Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J. of Surgical Research 59, 179-184.
2. Sielaff, T., Hu, M., Rao, S., Groehler, K., Olson, D., Mann, H., Remmel, R., Shatford, R., Amiot, B., Hu, W., and Cerra, F. (1995). A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation 59, 1459-1463
3. Garrett-Sinha, L., Su, G.H., Rao, S., Kabak, S., Hao, Z., Clark, M.R., and Simon, M.C. (1999). PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10, 399-408
4. Rao, S., Garrett-Sinha, L., Yoon, J., and Simon, M. C. (1999). The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor. J Biol Chem 274, 34245-52.
5. Rao, S., Matsumura, A., Yoon, J., and Simon, M. C. (1999). SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1. J Biol Chem 274, 11115-24.
6. Garrett-Sinha, L.A, Dahl, R., Rao, S., and Simon, M.C. (2001) PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. Blood 97, 2908-2912.
7. Hu, C.J., Rao, S., Ramirez-Bergeron, D.L., Gerondakis, S., and Simon, M.C. (2001) PU.1/Spi-B regulation of c-rel¬ is essential for mature B cell survival. Immunity 15, 545-555
8. Dahl, R., Ramirez-Bergeron, D.L., Rao, S., and Simon, M.C. (2002) Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. EMBO J 21, 2220-2230
9. Garrett-Sinha, L.A., Hou, P., Wang, D., Grabiner, B., Araujo, E., Rao, S. , Yun, T.J., Clark, E.A., Simon, M.C., Clark, M.R. (2005) Spi-1 and Spi-B control the expression of the Grap2 gene in B cells. Gene 20,134-146
10. Wang, J., Rao, S., Chu, J., Shen, X., Levasseur, D., Theunissen, T., Orkin, S.H.(2006) A protein interaction network for pluripotency of embryonic stem cells. Nature 44, 364-368
11. Rao, S., Shao, Z., Roumiantsev, S., McDonald, L., Yuan, G., Orkin, S.H. (2010) Differential Roles of Sall4 Isoforms in Embryonic Stem Cell Pluripotency. MCB 30, 5364-80
12. Koh, K., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A., Tahiliani, M., Sommer, C.A., Mostoslavsky, G., Lahesmaa, R., Orkin, S.H., Rodig, S.J., Daley, G.Q., Rao, A. (2011) Tet1 and Tet2 regulate 5-hydroxymethlcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell, 8, 200-213.
13. Gundry RL, Riordon DR, Tarasova Y, Chuppa S, Bhattacharya S, Juhasz O, Wiedemeier O, Milanovich S, Noto FK, Tchernyshyov I, Raginski K, Bausch-Fluck D, Tae HJ, Marshall S, Duncan SA, Wollscheid B, Wersto RP, Rao S, Van Eyk JE, Boheler KR. A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol Cell Proteomics. 2012 Aug;11(8):303-16. PMCID: PMC3412963
14. Pulakanti K, Pinello L, Stelloh C, Blinka S, Allred J, Milanovich S, Kiblawi S, Peterson J, Wang A, Yuan GC, Rao S. Enhancer transcribed RNAs arise from hypomethylated, Tet-occupied genomic regions. Epigenetics. 2013 Dec;8(12):1303-20. PMCID: PMC3933491
15. Boheler KR, Bhattacharya S, Kropp EM, Chuppa S, Riordon DR, Bausch-Fluck D, Burridge PW, Wu JC, Wersto RP, Chan GC, Rao S, Wollscheid B, Gundry RL. A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets. Stem Cell Reports. 2014 Jul 08;3(1):185-203. PMCID: PMC4110789
16. Milanovich S, Peterson J, Allred J, Stelloh C, Rajasekaran K, Fisher J, Duncan SA, Malarkannan S, Rao S. Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner. Exp Hematol. 2015 Jan;43(1):53-64.e1-8. PMCID: PMC4268405
17. Sohni A, Bartoccetti M, Khoueiry R, Spans L, Vande Velde J, De Troyer L, Pulakanti K, Claessens F, Rao S, Koh KP. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation. Mol Cell Biol. 2015 Mar;35(6):1026-42
18. Stelloh C, Reimer MH, Pulakanti K, Blinka S, Peterson J, Pinello L, Jia S, Roumiantsev S, Hessner MJ, Milanovich S, Yuan GC, Rao S. The cohesin-associated protein Wapal is required for proper Polycomb-mediated gene silencing. Epigenetics Chromatin. 2016;9:14. PMCID: PMC4832553
19. Swartz KL, Wood SN, Murthy T, Ramirez O, Qin G, Pillai MM, Rao S, Minella AC. E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts. Mol Cell Biol. 2017 01 01;37(1). PMCID: PMC5192079
20. Thompson CA, Wojta K, Pulakanti K, Rao S, Dawson P, Battle MA. GATA4 Is Sufficient to Establish Jejunal Versus Ileal Identity in the Small Intestine. Cell Mol Gastroenterol Hepatol. 2017 May;3(3):422-446. PMCID: PMC5404030
21. Zhang N, Zhi H, Curtis BR, Rao S, Jobaliya C, Poncz M, French DL, Newman PJ. CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes. Blood. 2016 Feb 11;127(6):675-80. PMCID: PMC4751021
22. Blinka S, Reimer MH Jr, Pulakanti K, Rao S. Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes. Cell Rep. 2016 09 27;17(1):19-28. PMCID: PMC5111363
23. Fisher JB, Peterson J, Reimer M, Stelloh C, Pulakanti K, Gerbec ZJ, Abel AM, Strouse JM, Strouse C, McNulty M, Malarkannan S, Crispino JD, Milanovich S, Rao S. The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9. Leukemia. 2017 03;31(3):712-719. PMCID: PMC5332284
24. Fisher JB, Pulakanti K, Rao S, Duncan SA. GATA6 is essential for endoderm formation from human pluripotent stem cells. Biol Open. 2017 Jul 15;6(7):1084-1095. PMCID: PMC5550920
25. Jing W, Gershan JA, Holzhauer S, Weber J, Palen K, McOlash L, Pulakanti K, Wesley E, Rao S, Johnson BD, Riese MJ. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia. Cancer Res. 2017 10 15;77(20):5676-5686.
26. Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J. Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. Blood Adv. 2017 Aug 22;1(19):1533-1536. PMCID: PMC5728466
27. Nanbakhsh A, Best B, Riese M, Rao S, Wang L, Medin J, Thakar MS, Malarkannan S. Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells. J Vis Exp. 2018 01 15(131). PMCID: PMC5908645
28. Newman DK, Fu G, McOlash L, Schauder D, Newman PJ, Cui W, Rao S, Johnson BD, Gershan JA, Riese MJ. Frontline Science: PECAM-1 (CD31) expression in naïve and memory, but not acutely activated, CD8<sup>+</sup> T cells. J Leukoc Biol. 2018 11;104(5):883-893. PMCID: PMC6195461
29. Volk A, Liang K, Suraneni P, Li X, Zhao J, Bulic M, Marshall S, Pulakanti K, Malinge S, Taub J, Ge Y, Rao S, Bartom E, Shilatifard A, Crispino JD. A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis. Cancer Cell. 2018 11 12;34(5):707-723.e7. PMCID: PMC6235627
30. Stoltz KP, Jondle CN, Pulakanti K, Sylvester PA, Urrutia R, Rao S, Tarakanova VL. Tumor suppressor Interferon Regulatory Factor 1 selectively blocks expression of endogenous retrovirus. Virology. 2019 01 02;526:52-60. PMCID: PMC6875439
31. Gupta AK, Murthy T, Paul KV, Ramirez O, Fisher JB, Rao S, Rosenberg AB, Seelig G, Minella AC, Pillai MM. Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1). Nucleic Acids Res. 2019 01 25;47(2):970-980. PMCID: PMC6344872
32. DeLaForest A, Di Furio F, Jing R, Ludwig-Kubinski A, Twaroski K, Urick A, Pulakanti K, Rao S, Duncan SA. HNF4A Regulates the Formation of Hepatic Progenitor Cells from Human iPSC-Derived Endoderm by Facilitating Efficient Recruitment of RNA Pol II. Genes (Basel). 2018 Dec 28;10(1). PMCID: PMC6356828
33. Ray A, Khalil MI, Pulakanti KL, Burns RT, Gurski CJ, Basu S, Wang D, Rao S, Dittel BN. Mature IgD<sup>low/-</sup> B cells maintain tolerance by promoting regulatory T cell homeostasis. Nat Commun. 2019 01 14;10(1):190. PMCID: PMC6331566
34. Izaguirre-Carbonell J, Christiansen L, Burns R, Schmitz J, Li C, Mokry RL, Bluemn T, Zheng Y, Shen J, Carlson KS, Rao S, Wang D, Zhu N. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia. Blood Adv. 2019 05 14;3(9):1499-1511. PMCID: PMC6517669
35. Reimer M Jr, Pulakanti K, Shi L, Abel A, Liang M, Malarkannan S, Rao S. Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression. BMC Dev Biol. 2019 07 08;19(1):16. PMCID: PMC6615237
36. Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, Routes JM, Verbsky JW, Thakar MS, Malarkannan S. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat Commun. 2019 09 02;10(1):3931. PMCID: PMC6718415
37. Gao C, Schroeder JA, Xue F, Jing W, Cai Y, Scheck A, Subramaniam S, Rao S, Weiler H, Czechowicz A, Shi Q. Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Adv. 2019 09 24;3(18):2700-2711. PMCID: PMC6759737
38. Nanbakhsh A, Srinivasamani A, Holzhauer S, Riese MJ, Zheng Y, Wang D, Burns R, Reimer MH, Rao S, Lemke A, Tsaih SW, Flister MJ, Lao S, Dahl R, Thakar MS, Malarkannan S. <i>Mirc11</i> Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells. Cancer Immunol Res. 2019 10;7(10):1647-1662.
39. Mishra MK, Liang EY, Geurts AM, Auer PWL, Liu P, Rao S, Greene AS, Liang M, Liu Y. Comparative and Functional Genomic Resource for Mechanistic Studies of Human Blood Pressure-Associated Single Nucleotide Polymorphisms. Hypertension. 2020 Mar;75(3):859-868. PMCID: PMC7035167
40. Murthy T, Bluemn T, Gupta AK, Reimer M Jr, Rao S, Pillai MM, Minella AC. Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin. J Biol Chem. 2018 06 29;293(26):10220-10234. PMCID: PMC6028971
41. Dausinas P, Pulakanti K, Rao S, Cole JM, Dahl R, Cowden Dahl KD. ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells. Gene. 2020 May 15;738:144458.
42. Yang C, Siebert JR, Burns R, Zheng Y, Mei A, Bonacci B, Wang D, Urrutia RA, Riese MJ, Rao S, Carlson KS, Thakar MS, Malarkannan S. Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature. Elife. 2020 May 14;9. PMCID: PMC7255804
 
Books, Chapters, and Reviews
1. Rao, S., and Simon, M. C. (2000). The role of PU.1 in B-lymphocyte development and function. In: Transcriptional regulation in normal and malignant hematopoiesis, J. Licht and K. Ravid, eds. (Boston: McGraw-Hill).
2. Rao, S., Orkin, S.H., (2006) Unraveling the transcriptional network controlling ES cell pluripotency. Genome Biology 7, 230
3. Orkin, S. H. Wang, J., Kim, J., Chu, J., Rao, S., Theunissen, T.W., Shen, X., and Levasseur, D.N. in Cold Spring Harbor Symposia on Quantitative Biology Vol. LXXIII (Cold Spring Harbor Laboratory Press, Cold Spring Harbor Laboratory 2008)
4. Wang, J., Trowbridge, J. J., Rao, S. & Orkin, S. H. Vol. StemBook.1.4.1 (eds B. E. Bernstein & I. Lemischka) (stembook.org, 2008).
5. Rao S. Embryonic Stem Cells: A Perfect Tool for Studying Mammalian Transcriptional Enhancers. J Stem Cell Res Ther. 2012 Jul 05;Suppl 10. PMCID: PMC3844140
6. Abel AM, Schuldt KM, Rajasekaran K, Hwang D, Riese MJ, Rao S, Thakar MS, Malarkannan S. IQGAP1: insights into the function of a molecular puppeteer. Mol Immunol. 2015 Jun;65(2):336-49. PMCID: PMC4480615
7. Rajasekaran K, Riese MJ, Rao S, Wang L, Thakar MS, Sentman CL, Malarkannan S. Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy. Front Immunol. 2016;7:176. PMCID: PMC4863891
8. Blinka S, Reimer MH Jr, Pulakanti K, Pinello L, Yuan GC, Rao S. Identification of Transcribed Enhancers by Genome-Wide Chromatin Immunoprecipitation Sequencing. Methods Mol Biol. 2017;1468:91-109. PMCID: PMC5111358
9. Fisher JB, McNulty M, Burke MJ, Crispino JD, Rao S. Cohesin Mutations in Myeloid Malignancies. Trends Cancer. 2017 04;3(4):282-293. PMCID: PMC5472227
10. Blinka S and S Rao. Nanog Expression in Embryonic Stem Cells-an Ideal Model System to Dissect Enhancer Function BioEssays. .
11. Blinka S, Rao S. Nanog Expression in Embryonic Stem Cells - An Ideal Model System to Dissect Enhancer Function. Bioessays. 2017 Dec;39(12). PMCID: PMC5878941
12. Agrawal P, Heimbruch KE, Rao S. Genome-Wide Maps of Transcription Regulatory Elements and Transcription Enhancers in Development and Disease. Compr Physiol. 2018 12 13;9(1):439-455. PMCID: PMC6566905
13. Tang J, Zhu N, Rao S, Carlson KS. Stem cell damage after chemotherapy- can we do better? Best Pract Res Clin Haematol. 2019 03;32(1):31-39.
14. Orkin SH, Wang J, Kim J, Chu J, Rao S, Theunissen TW, Shen X, Levasseur DN. The transcriptional network controlling pluripotency in ES cells. Cold Spring Harb Symp Quant Biol. 2008;73:195-202.
 
Editorials, Letters to Editor, Other
1. A Meyer, S Rao, J Fisher. Cohesin mutations: contributors to myeloid malignancies Oncotarget. .
2. Rao S. Closing the loop on cohesin in hematopoiesis. Blood. 2019 12 12;134(24):2123-2125. PMCID: PMC6908834
 

jenkins-FCD Prod-466 5b81815b8b3d1f46bfec16512ed5f574613f59c5